Foghorn Therapeutics Inc.
USD4.86
+0.64 (+15.17%)
CEO
Adrian H. Gottschalk
IPO Date
2020-10-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.27
Prev. Close
$4.22
Day Low
$4.17
Day High
$4.96
52W Low
$3.27
52W High
$6.95
Market Cap
$0.29B
Volume
0.38M
| -3.0 |
| 31 Dec 2023 | FY | 100.0% | -288.2% | 127.5% | -34.4% | -0.58 | 4.11 | -2.8 |
| 31 Dec 2022 | FY | 100.0% | -566.3% | -97216.1% | -26.9% | 459.88 | 6.37 | -2.4 |
| 31 Dec 2021 | FY | 100.0% | -7681.6% | -104.6% | -19.5% | 0.60 | 9.44 | -8.4 |
| 31 Dec 2020 | FY | -13322.1% | -16000.0% | -47.1% | -26.9% | 0.56 | 10.12 | -10.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 58.1% | -228.8% | -0.19 | 1.33 | -13.0 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 67.1% | -61.2% | -0.18 | 11.68 | -13.5 |
| -3.9 |
| 30 Sept 2025 | Q3 | -145.3% | -194.4% | 17.7% | -7.7% | -0.25 | 2.16 | -4.9 |
| 30 Jun 2025 | Q2 | 88.1% | -237.3% | 23.4% | -7.9% | -0.31 | 2.62 | -4.1 |
| 31 Mar 2025 | Q1 | 100.0% | -316.4% | 30.5% | -7.3% | -0.57 | 3.16 | -3.0 |
| 31 Dec 2024 | Q4 | 100.0% | -682.9% | 42.8% | -6.9% | -0.82 | 3.73 | -3.8 |
| 30 Sept 2024 | Q3 | 100.0% | -244.9% | 67.6% | -6.2% | -1.38 | 4.77 | -7.6 |
| 30 Jun 2024 | Q2 | 100.0% | -333.6% | 160.4% | -7.0% | -2.86 | 5.69 | -3.3 |
| 31 Mar 2024 | Q1 | 100.0% | -495.4% | 25.7% | -9.8% | -0.44 | 4.06 | -3.0 |
| 31 Dec 2023 | Q4 | 85.2% | -417.9% | 31.2% | -8.4% | -0.58 | 4.11 | -2.8 |